A detailed history of Garrison Point Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Garrison Point Advisors, LLC holds 16,331 shares of BMY stock, worth $936,256. This represents 0.53% of its overall portfolio holdings.

Number of Shares
16,331
Previous 16,866 3.17%
Holding current value
$936,256
Previous $700,000 20.71%
% of portfolio
0.53%
Previous 0.47%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$39.66 - $51.75 $21,218 - $27,686
-535 Reduced 3.17%
16,331 $845,000
Q2 2024

Aug 07, 2024

SELL
$40.25 - $52.99 $24,311 - $32,005
-604 Reduced 3.46%
16,866 $700,000
Q1 2024

May 09, 2024

SELL
$47.98 - $54.4 $19,192 - $21,760
-400 Reduced 2.24%
17,470 $947,000
Q4 2023

Feb 08, 2024

SELL
$48.48 - $57.85 $19,682 - $23,487
-406 Reduced 2.22%
17,870 $916,000
Q3 2023

Oct 17, 2023

SELL
$57.89 - $64.73 $11,809 - $13,204
-204 Reduced 1.1%
18,276 $1.06 Million
Q2 2023

Jul 25, 2023

SELL
$63.71 - $70.74 $8,282 - $9,196
-130 Reduced 0.7%
18,480 $1.18 Million
Q1 2023

May 05, 2023

SELL
$65.71 - $74.53 $1,708 - $1,937
-26 Reduced 0.14%
18,610 $1.29 Million
Q2 2022

Aug 10, 2022

BUY
$72.62 - $79.98 $7,262 - $7,998
100 Added 0.54%
18,636 $1.44 Million
Q3 2021

Nov 04, 2021

BUY
$59.17 - $69.31 $7,100 - $8,317
120 Added 0.65%
18,536 $1.1 Million
Q2 2021

Aug 02, 2021

BUY
$61.91 - $67.42 $6,562 - $7,146
106 Added 0.58%
18,416 $1.23 Million
Q1 2021

May 04, 2021

SELL
$59.34 - $66.74 $4,153 - $4,671
-70 Reduced 0.38%
18,310 $1.16 Million
Q4 2020

Jan 28, 2021

BUY
$57.74 - $65.43 $28,003 - $31,733
485 Added 2.71%
18,380 $1.14 Million
Q3 2020

Oct 27, 2020

SELL
$57.43 - $63.64 $5,743 - $6,364
-100 Reduced 0.56%
17,895 $1.08 Million
Q2 2020

Aug 03, 2020

SELL
$54.82 - $64.09 $26,203 - $30,635
-478 Reduced 2.59%
17,995 $1.06 Million
Q1 2020

Apr 20, 2020

SELL
$46.4 - $67.43 $21,761 - $31,624
-469 Reduced 2.48%
18,473 $1.03 Million
Q4 2019

Jan 24, 2020

BUY
$49.21 - $64.19 $323,063 - $421,407
6,565 Added 53.04%
18,942 $1.22 Million
Q4 2018

Feb 11, 2019

BUY
$48.76 - $63.23 $603,502 - $782,597
12,377 New
12,377 $643,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Garrison Point Advisors, LLC Portfolio

Follow Garrison Point Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Garrison Point Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Garrison Point Advisors, LLC with notifications on news.